98%
921
2 minutes
20
Identifying molecular mediators of neural circuit development and/or function that contribute to circuit dysfunction when aberrantly reengaged in neurological disorders is of high importance. The role of the TWEAK/Fn14 pathway, which was recently reported to be a microglial/neuronal axis mediating synaptic refinement in experience-dependent visual development, has not been explored in synaptic function within the mature central nervous system. By combining electrophysiological and phosphoproteomic approaches, we show that TWEAK acutely dampens basal synaptic transmission and plasticity through neuronal Fn14 and impacts the phosphorylation state of pre- and postsynaptic proteins in adult mouse hippocampal slices. Importantly, this is relevant in two models featuring synaptic deficits. Blocking TWEAK/Fn14 signaling augments synaptic function in hippocampal slices from amyloid-beta-overexpressing mice. After stroke, genetic or pharmacological inhibition of TWEAK/Fn14 signaling augments basal synaptic transmission and normalizes plasticity. Our data support a glial/neuronal axis that critically modifies synaptic physiology and pathophysiology in different contexts in the mature brain and may be a therapeutic target for improving neurophysiological outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017933 | PMC |
http://dx.doi.org/10.1073/pnas.2001679118 | DOI Listing |
World J Gastroenterol
August 2025
Department of General Surgery, Wujin Hospital Affiliated with Jiangsu University, Changzhou 213162, Jiangsu Province, China.
Background: The progression of non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH) and liver fibrosis remains poorly understood, though liver sinusoidal endothelial cells (LSECs) are thought to play a central role in disease pathogenesis.
Aim: To investigate the role of in NAFLD fibrosis through its regulation of LSEC dysfunction and macrophage polarization.
Methods: We analysed single-cell transcriptomic data (GSE129516) from NASH and normal mouse models and identified as a key regulator in LSECs.
Cells
August 2025
Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USA.
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a systemic ciliopathy resulting from loss-of-function mutations in the PKD1 and PKD2 genes, which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. PC1 and PC2 regulate mechanosensation, calcium signaling, and key pathways controlling tubular epithelial structure and function. Loss of PC1/PC2 disrupts calcium homeostasis, elevates cAMP, and activates proliferative cascades such as PKA-B-Raf-MEK-ERK, mTOR, and Wnt, driving cystogenesis via epithelial proliferation, impaired apoptosis, fluid secretion, and fibrosis.
View Article and Find Full Text PDFInt J Mol Med
October 2025
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China.
Fibroblast‑like synoviocytes (FLSs) are the primary drivers of synovial tissue hyperplasia in rheumatoid arthritis (RA). Activation of the tumor necrosis factor‑like weak inducer of apoptosis (TWEAK)/fibroblast growth factor‑inducible immediate‑early response protein 14 (Fn14) pathway significantly contributes to the pathogenesis of RA. Kirenol (Kir), a compound with anti‑inflammatory and antirheumatic properties, has an unclear mechanism of action.
View Article and Find Full Text PDFiScience
July 2025
Institute of Muscle Biology and Cachexia, University of Houston College of Pharmacy, Houston, TX, USA.
Cancer cachexia is a multifactorial syndrome characterized by progressive skeletal muscle wasting. The TWEAK-Fn14 system regulates muscle mass in diverse conditions. However, its role in the regulation of muscle mass during cancer cachexia remains less understood.
View Article and Find Full Text PDFACS Omega
May 2025
College of Basic Medical Sciences, Zhejiang Chinese Medical University, Zhejiang, Hangzhou 310053, China.
The objective of this study was to investigate the mechanism through which catalpol (CAT) exerts its protective effects in the context of myocardial ischemia-reperfusion injury. Preliminary results showed that Cat significantly attenuated oxygen-glucose deprivation/reoxygenation (OGD/R) damage to H9C2 cells, inhibited intracellular reactive oxygen species levels, and downregulated the protein expression of TWEAK and Fn14 post-OGD/R. The intracellular level of miR-126 was downregulated after OGD/R, and this effect was reversed by CAT administration.
View Article and Find Full Text PDF